NervGen Pharma Statistics

Total Valuation

NervGen Pharma has a market cap or net worth of 200.24 million. The enterprise value is 188.95 million.

Market Cap	200.24M
Enterprise Value	188.95M

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	73.28M
Shares Outstanding	n/a
Shares Change (YoY)	+13.09%
Shares Change (QoQ)	+1.82%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	61.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-297.36
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.58
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.92

Current Ratio	0.92
Quick Ratio	0.89
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -464.75% and return on invested capital (ROIC) is -280.83%.

Return on Equity (ROE)	-464.75%
Return on Assets (ROA)	-73.83%
Return on Invested Capital (ROIC)	-280.83%
Return on Capital Employed (ROCE)	2,881.73%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.50% in the last 52 weeks. The beta is 0.64, so NervGen Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+36.50%
50-Day Moving Average	2.52
200-Day Moving Average	2.31
Relative Strength Index (RSI)	59.51
Average Volume (20 Days)	85,981

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.41M
Pretax Income	-19.71M
Net Income	-19.71M
EBITDA	-19.38M
EBIT	-19.41M
Earnings Per Share (EPS)	-0.28

Full Income Statement

Balance Sheet

The company has 11.49 million in cash and 42,316 in debt, giving a net cash position of 11.45 million.

Cash & Cash Equivalents	11.49M
Total Debt	42,316
Net Cash	11.45M
Net Cash Per Share	n/a
Equity (Book Value)	-673,398
Book Value Per Share	-0.01
Working Capital	-993,857

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.61M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NervGen Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.09%
Shareholder Yield	n/a
Earnings Yield	-9.84%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1